SEC 13F Intelligence

Los Angeles Capital Management LLC / VRTX

Los Angeles Capital Management LLC’s Vertex Pharmaceuticals Inc Position

Does Los Angeles Capital Management LLC own Vertex Pharmaceuticals Inc (VRTX)? Yes — 64.9K shares worth $29M (+0.11% of its 13F portfolio) as of Q1 2026, down from 293.3K shares the prior filed quarter.

Position Value
$29M
Q1 2026
Shares
64.9K
% of Portfolio
+0.11%
Quarters Held
30
currently held

Position History VRTX

Reported value by quarter
Q4 ’18: $73MQ4 ’18Q1 ’19: $80MQ2 ’19: $80MQ3 ’19: $65MQ4 ’19: $67MQ4 ’19Q1 ’20: $74MQ2 ’20: $97MQ3 ’20: $86MQ4 ’20: $73MQ4 ’20Q1 ’21: $48MQ2 ’21: $34MQ3 ’21: $28MQ4 ’21: $66MQ4 ’21Q1 ’22: $93MQ2 ’22: $95MQ3 ’22: $126MQ4 ’22: $129MQ4 ’22Q1 ’23: $144MQ2 ’23: $150MQ3 ’23: $149MQ4 ’23: $159MQ4 ’23Q1 ’24: $55MQ2 ’24: $30MQ3 ’24: $9MQ4 ’24: $524,315Q4 ’24Q1 ’25: $12MQ2 ’25: $15MQ3 ’25: $14MQ4 ’25: $123MQ4 ’25Q1 ’26: $29Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202664.9K$29M+0.11%
Q4 2025293.3K$123M+0.42%
Q3 202535.5K$14M+0.05%
Q2 202533.0K$15M+0.06%
Q1 202525.7K$12M+0.06%
Q4 20241.3K$524,3150.00%
Q3 202418.7K$9M+0.04%
Q2 202464.7K$30M+0.11%
Q1 2024132.7K$55M+0.19%
Q4 2023389.9K$159M+0.59%
Q3 2023427.1K$149M+0.63%
Q2 2023426.2K$150M+0.60%
Q1 2023457.2K$144M+0.64%
Q4 2022447.0K$129M+0.63%
Q3 2022434.5K$126M+0.65%
Q2 2022337.5K$95M+0.47%
Q1 2022354.8K$93M+0.36%
Q4 2021302.0K$66M+0.25%
Q3 2021154.1K$28M+0.13%
Q2 2021169.4K$34M+0.15%
Q1 2021224.4K$48M+0.22%
Q4 2020307.1K$73M+0.31%
Q3 2020316.3K$86M+0.40%
Q2 2020332.9K$97M+0.47%
Q1 2020310.5K$74M+0.47%
Q4 2019306.1K$67M+0.33%
Q3 2019383.6K$65M+0.35%
Q2 2019434.0K$80M+0.43%
Q1 2019435.0K$80M+0.44%
Q4 2018442.0K$73M+0.45%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Los Angeles Capital Management LLC’s full portfolio or all institutional holders of VRTX.